Cell cycle arrest induction and triggering apoptosis in cancer cell lines treated with BCP was reported to occur through upregulating reactive oxygen species (ROS), inducing mitochondrial dysfunction, activating caspases and Bax, or downregulating Bcl-2 in these cells. This evidence concerns the gene BCL2 and cancer.